COVIDIEN PLC | 49,764 Euro | -0,132 -0,26 % | |
| WKN: A1H7XB ISIN: IE00B68SQD29 Ticker-Symbol: 6COP | Frankfurt | 24.05.13 | 08:18 Uhr |
Branche GesundheitswesenAktienmarkt S&P 500 |
|
|
| Zeit | Aktuelle Nachrichten
Sprache: | Leser | Medien | |
|---|---|---|---|---|
| 14:45 | Covidien plc - 8-K, Current Report | - | SEC Filings | |
| 14:19 | Covidien to Issue 8 Mallinckrodt Shares for Each Covidien Share in Spinoff | - | Euroinvestor | |
| 13:33 | Covidien's board gives green light to 'MNK' | - | bizjournals | |
| 13:04 | Covidien Board Approves Separation of Pharmaceuticals Business | - | Benzinga.com | |
| 13:02 | Covidien Board of Directors Approves Separation of Pharmaceuticals Business and Declares Dividend of Mallinckrodt Ordinary Shares | 44 | Business Wire | |
| Covidien plc (NYSE: COV), a leading global provider of healthcare products, today announced that its board of directors has approved the separation of the Pharmaceuticals business from... Mehr lesen zu: Covidien Board of Directors Approves Separation of Pharmaceuticals Business and Declares Dividend of Mallinckrodt Ordinary Shares | ||||
| 08:49 | Covidien meldet Ergebnisse der ersten Studie zu neuem medikamentenbeschichtetem Ballonkatheter am Menschen | 40 | Business Wire | |
| FIH-Studie ILLUMENATE bringt vielversprechende Sicherheits- und Wirksamkeitsergebnisse bei der Behandlung der peripheren arteriellen Verschlusskrankheit Covidien, ein weltweit führender... Mehr lesen zu: Covidien meldet Ergebnisse der ersten Studie zu neuem medikamentenbeschichtetem Ballonkatheter am Menschen | ||||
| 08:02 | Covidien Releases Results from First-in-Human Study of New Drug-Coated Balloon | 75 | Business Wire | |
| ILLUMENATE FIH Study Delivers Promising Safety and Effectiveness Data for Treatment of Peripheral Arterial Disease Covidien, a leading global provider of healthcare products, announced... Mehr lesen zu: Covidien Releases Results from First-in-Human Study of New Drug-Coated Balloon | ||||
| 23.05. | Covidien's ENB Adopted by ACCP | - | Zacks | |
| 22.05. | Covidien Says Trial Data for Endoscopic Ablation Therapy Shows Elimination of Precancerous Esophageal Tissue, Significantly Cut Disease Progression | - | Benzinga.com | |
| 22.05. | Covidien Announces Clinical Trial Data Showing Endoscopic Ablation Therapy Eliminates Precancerous Esophageal Tissue and Significantly Reduces Disease Progression | 36 | Business Wire | |
| Endoscopic ablation in patients with Barrett's esophagus containing confirmed low-grade dysplasia reduces the relative risk for disease progression by 94% as compared to controls Covidien... Mehr lesen zu: Covidien Announces Clinical Trial Data Showing Endoscopic Ablation Therapy Eliminates Precancerous Esophageal Tissue and Significantly Reduces Disease Progression | ||||
| 22.05. | Covidien gibt klinische Studienergebnisse bekannt, die zeigen, dass endoskopische Ablationstherapie präkanzeröses Speiseröhrengewebe beseitigt und das Fortschreiten der Erkrankung deutlich verlangsamt | 24 | Business Wire | |
| Endoskopische Ablation bei Barrett-Ösophagus-Patienten mit nachgewiesener geringgradiger Dysplasie senkt relatives Risiko der Krankheitsprogression um 94% im Vergleich zur Kontrollgruppe... Mehr lesen zu: Covidien gibt klinische Studienergebnisse bekannt, die zeigen, dass endoskopische Ablationstherapie präkanzeröses Speiseröhrengewebe beseitigt und das Fortschreiten der Erkrankung deutlich verlangsamt | ||||
| 21.05. | Covidien's lung cancer detection system included in ACCP guidelines | - | bizjournals | |
| 16.05. | Covidien Prices Senior Notes | - | Zacks | |
| 14.05. | Covidien, others join together to find jobs for vets | - | bizjournals | |
| 13.05. | Covidien Announces Pricing of $750 Million Senior Notes Offering | 47 | Business Wire | |
| Covidien plc (NYSE: COV) today announced that its wholly-owned subsidiary, Covidien International Finance S.A. (CIFSA), priced an underwritten offering of $750 million aggregate principal... Mehr lesen zu: Covidien Announces Pricing of $750 Million Senior Notes Offering | ||||
| 10.05. | Covidien plc - 8-K, Current Report | - | SEC Filings | |
| 09.05. | Covidien Is Growing Where Others Don't | - | The Street | |
| 08.05. | Covidien Aiming For Mallinckrodt Spin-Out | 1 | Seeking Alpha | |
| 06.05. | Covidien plc, 2013 Guidance/Update Call, May 06, 2013 | - | Seeking Alpha | |
| 06.05. | Covidien Provides 2013 Outlook | 1 | Zacks | |
